bovine lactoferrin
Animal productexperimental
Clinical trial activity
28 trials · 37 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
9
Phase 3
5
Phase 4
4
Earliest trial started Feb 29, 2008 (NCT00560222)
Timeline
Indications
Approved for
Studied for
- Bronchiectasis · Phase 1
- COVID-19 · Phase 4
- Cystic Fibrosis · Phase 1
- Diarrhea · Phase 3
- Enterocolitis, Necrotizing · Phase 3
- Helicobacter pylori · Phase 4
- Hepatic Encephalopathy · Phase 2
- Infant, Premature · Phase 3
- Infant, Very Low Birth Weight · Phase 3
- Intestinal Neoplasms · Phase 1
- Iron Deficiencies · Phase 4
- Malnutrition · Phase 3
- Mycoses · Phase 1
- Neonatal Sepsis · Phase 3
- Neonatology · Phase 3
- Pregnancy Complications · Phase 4
- SARS-CoV-2 · Phase 2
- Urinary Tract Infections · Phase 3
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- blf
- bovine lactoferrin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06072521 | Phase 2 | Oct 31, 2023 | Al Azhar University, National Hepatology & Tropical Medicine Research Institute |
| NCT05783180 | Phase 2 | Jun 30, 2023 | Keralty Hospital, Miami |
| NCT06015828 | N/A | Sep 20, 2021 | Ain Shams University, Al Azhar University |
| NCT04713735 | N/A | Feb 8, 2021 | Mead Johnson |
| NCT04710381 | Phase 4 | Feb 1, 2021 | University of Ostrava |
| NCT04847791 | N/A | Jan 14, 2021 | ASL Bari, Paolo Manzoni |
| NCT04738058 | Phase 1 | Dec 15, 2020 | Mansoura University |
| NCT04526821 | Phase 2 | Sep 1, 2020 | Cayetano Heredia University |
| NCT04432935 | N/A | Jul 1, 2020 | Aga Khan University, Centers for Disease Control and Prevention (CDC) |
| NCT05283278 | Phase 1 | Feb 10, 2020 | Ain Shams University |
| NCT04445948 | Phase 4 | Nov 30, 2019 | Alexandria University |
| NCT03866837 | N/A | Apr 30, 2019 | Columbia University, Jomo Kenyatta University of Agriculture and Technology, Swiss Federal Institute of Technology |
| NCT03490279 | N/A | Jun 1, 2018 | University of Pavia |
| NCT03431558 | Phase 3 | May 1, 2018 | Aga Khan University, United States Agency for International Development, University of Sydney |
| NCT03367013 | Phase 3 | Feb 16, 2018 | Canadian Institutes of Health Research (CIHR), National Health and Medical Research Council, Australia, University of Toronto |
| NCT04267653 | Phase 4 | Jan 1, 2018 | Assiut University |
| NCT03472170 | N/A | May 29, 2017 | Universidad de Cordoba |
| NCT07113314 | N/A | Oct 6, 2016 | University of Pavia |
| NCT02626104 | Phase 2 | Dec 1, 2015 | Medical University of Warsaw, Pharmabest Sp. z o.o. |
| NCT02598999 | Phase 1 | Nov 1, 2015 | Eurofins, STRAGEN |
Showing 20 of 28 trials
Page 1 / 2
Organizations
Research & Development (37)
37 organizations
Page 1 / 2